Emergent BioSolutions (EBS) is down -16.0%, or -$1.09 to $5.74.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Positive Outlook for Emergent Biosolutions: Buy Rating Supported by Strong Contract Wins and Financial Recovery
- Emergent BioSolutions Reports Strong 2024 Financial Turnaround
- Closing Bell Movers: Okta spikes 15% on earnings beat and outlook
- Emergent BioSolutions Reports 2024 Financial Results
- Emergent BioSolutions sees Q1 revenue $200M-$240M, consensus $279M